Next Article in Journal / Special Issue
Pharmacogenomics: Current State-of-the-Art
Previous Article in Journal / Special Issue
The Little Fly that Could: Wizardry and Artistry of Drosophila Genomics
Genes 2014, 5(2), 415-429; doi:10.3390/genes5020415

Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells

1 Genethon, 1bis Rue de l'Internationale, 91020 Evry, France 2 Institute of Experimental Hematology, Hannover Medical School, Carl-Neuberg-Str.1, D-30625 Hannover, Germany 3 Institute for Biomedical Technologies, Consiglio Nazionale delle Ricerche, Milan 20132, Italy
* Author to whom correspondence should be addressed.
Received: 3 March 2014 / Revised: 30 April 2014 / Accepted: 6 May 2014 / Published: 16 May 2014
(This article belongs to the Special Issue Grand Celebration: 10th Anniversary of the Human Genome Project)
View Full-Text   |   Download PDF [750 KB, uploaded 16 May 2014]   |   Browse Figures


Gene transfer vectors derived from gamma-retroviruses or lentiviruses are currently used for the gene therapy of genetic or acquired diseases. Retroviral vectors display a non-random integration pattern in the human genome, targeting either regulatory regions (gamma-retroviruses) or the transcribed portion of expressed genes (lentiviruses), and have the potential to deregulate gene expression at the transcriptional or post-transcriptional level. A recently developed alternative vector system derives from the avian sarcoma-leukosis alpha-retrovirus (ASLV) and shows favorable safety features compared to both gamma-retroviral and lentiviral vectors in preclinical models. We performed a high-throughput analysis of the integration pattern of self-inactivating (SIN) alpha-retroviral vectors in human CD34+ hematopoietic stem/progenitor cells (HSPCs) and compared it to previously reported gamma-retroviral and lentiviral vectors integration profiles obtained in the same experimental setting. Compared to gamma-retroviral and lentiviral vectors, the SIN-ASLV vector maintains a preference for open chromatin regions, but shows no bias for transcriptional regulatory elements or transcription units, as defined by genomic annotations and epigenetic markers (H3K4me1 and H3K4me3 histone modifications). Importantly, SIN-ASLV integrations do not cluster in hot spots and target potentially dangerous genomic loci, such as the EVI2A/B, RUNX1 and LMO2 proto-oncogenes at a virtually random frequency. These characteristics predict a safer profile for ASLV-derived vectors for clinical applications.
Keywords: retroviral integration; alpha-retroviral vectors; gene therapy; human hematopoietic cells retroviral integration; alpha-retroviral vectors; gene therapy; human hematopoietic cells
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary material

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Moiani, A.; Suerth, J.D.; Gandolfi, F.; Rizzi, E.; Severgnini, M.; De Bellis, G.; Schambach, A.; Mavilio, F. Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells. Genes 2014, 5, 415-429.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert